Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The French biotech regains momentum during the session, as the Paris market trends upward. The stock is among the best performers of the SBF 120 at mi…
French biotech Abivax is up 2.11% at €99.15 in early afternoon trading, in a Paris market trending upwards. The SBF 120 is up 0.55% during the session…
French biotech Abivax has gained 2.35% to €97.85 by midday this Tuesday, May 19, 2026. The stock is performing in a well-oriented Parisian market, wit…
The French biotech continues its ascent this Wednesday morning. The stock is up 4.74% at €110.50, after closing at €105.50 the previous day. The incre…
French biotech company Abivax sees significant midday gains on Tuesday, reaching €105 after announcing a combined financing operation and a royalty bu…
Abivax has announced the buyback of its Royalty Certificates. The company is also issuing $45 million (€38.5 million) in American Depositary Shares.
The French biotech progresses to €101.80 in mid-session on Monday, marking a 5.55% increase from the last close of €96.45. The movement occurs during …
French biotech company Abivax sees a 2.93% drop during Wednesday's session on April 29, trading at €92.75, in a generally declining Paris market. The …
Abivax announces the presentation of nine scientific abstracts focused on obefazimod at the Digestive Disease Week conference, scheduled from May 2 to…
Abivax announces nine scientific abstracts concerning obebazimod at the Digestive Disease Week, scheduled from May 2 to May 5, 2026, in Chicago. These…
